
Sign up to save your podcasts
Or


Dr. Bo Xu, of the Chinese Academy of Medical Sciences, discusses the results of the FUTURE-II trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, showed comparable safety and efficacy between the thin-strut Chinese Firesorb bioresorbable vascular scaffold and the cobalt-chromium everolimus-eluting Xience stents
By Conversations That Inspire5
44 ratings
Dr. Bo Xu, of the Chinese Academy of Medical Sciences, discusses the results of the FUTURE-II trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, showed comparable safety and efficacy between the thin-strut Chinese Firesorb bioresorbable vascular scaffold and the cobalt-chromium everolimus-eluting Xience stents

163 Listeners

895 Listeners

135 Listeners

67 Listeners

38 Listeners

18 Listeners